About Conference
Participants will explore the latest treatment guidelines for lupus nephritis, IgA nephropathy, ANCA vasculitis, and monoclonal gammopathy. They will understand the importance of individualized treatment plans based on disease severity, patient characteristics, and comorbidities. Participants will understand target therapies' (including complement inhibitors, B cell targeted therapies, endothelin-angiotensin system modulators, and plasma cell therapies)
Highlights
the course will cover the mechanisms through which these drugs improve renal outcomes in diabetic patients and explore the evidence supporting their use in reducing proteinuria and preserving renal function. There will be case studies and real-world scenarios - participants will be encouraged to engage in interactive discussions to analyze and develop appropriate treatment plans based on each case
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
2.
Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer
3.
Taking vitamin D daily decreased cancer mortality, according to a study.
4.
Study reveals increase in late-stage breast cancer diagnoses in US
5.
Prostate cancer Q&A: Improving detection and reducing overtreatment
1.
Virtual Survivorship Platforms in Cancer Care: Transforming Post-Treatment Support and Outcomes
2.
Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment
3.
Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025
4.
The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide
5.
Women's Cancer Survivorship: Emerging Long-Term Health Priorities
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
3.
Expert Perspectives on Hematology
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Navigating the Complexities of Ph Negative ALL - Part VIII
Recommended News For You
1.
Pickleball program boosts health and wellness for cancer survivors, study finds
2.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
3.
Francis Collins reveals that he was diagnosed with "aggressive" prostate cancer.
4.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
5.
Increased detection of adenomas may reduce colon cancer risk after colonoscopy in FIT-based screening.
Conferences That Might Interest You
Recommended Articles For You
1.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
2.
Metabolic Plasticity in the Progression of Solid Tumors
3.
Digital Morphology Libraries for Hematology Education: Transforming Diagnostic Training and Clinical Practice
4.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
5.
Early Recognition of Immune-Related Adverse Events During Cancer Therapy
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge